J.B. Chemicals & Pharmaceuticals gets approval to sell its over-the-counter biz

24 May 2011 Evaluate

J.B. Chemicals & Pharmaceuticals (JBCPL) has received its board’s approval for entering into a definitive agreement to sell its Russia/CIS OTC Business to Cilag GmbH International, a wholly owned subsidiary of Johnson & Johnson. The consideration for this transaction is Rs 9,385.10 million.

Further, the board has also approved the sale of worldwide rights and registrations of 3 OTC brands (Doktor Mom, Rinza and Fitovit) to Cilag, for an additional consideration of Rs 60.67 million. The Russia/CIS OTC Business is being sold as a going concern on a slump sale basis including OTC trademarks, brands, patents, registrations and domain names. The sale will also involve the transfer of the employees of the Russia/ CIS OTC Business.

Cilag‘s affiliate, Johnson & Johnson LLC, has also entered into a contract with the company’s wholly owned subsidiary situated in Russia for purchase of its OTC inventory and receivables for a consideration of $47 million. In addition, the company has signed a long term agreement to supply Cilag finished products for the acquired Russia/CIS OTC Business. The transaction is expected to close in mid 2011.

JBCPL is one of India’s leading pharmaceutical companies which manufacture and markets a diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×